science
Why GLP-1 drugs are under fresh scrutiny over a rare eye condition linked to vision loss
GLP-1 drugs face fresh scrutiny over NAION, a rare eye condition linked to sudden vision loss, as studies, regulators and US lawsuits examine the risk.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Abolis launches MINE to turn microbial data into industrial action
Indianpharmapost
ASMS & Huwel Lifesciences step up push to take Cubo RT-PCR platform across India
Indianpharmapost
Steering the biotech bus India's way
The New Indian Express
A Cosmic “Shrimp” With A Hidden Secret: NASA Reveals The Strange Motion Behind This Nebula
The Daily Galaxy
EVolve Conclave: Leaders discuss scaling electric mobility in India
Asianet Newsable